13 Best Growth Stocks Under $25 to Buy Right Now

Page 9 of 12

​4. Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Price: $19.30

Number of Hedge Fund Holders: 57

​Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 9, Jason Gerberry from Bank of America Securities raised the firm’s price target on Teva Pharmaceutical Industries Limited (NYSE:TEVA) from $22 to $24 while keeping a Buy rating on the stock.

​The analyst noted that they previewed their EPS estimates for commercial-stage biotech companies. As per the Q3 pricing volume trends on key drugs, the company does not expect any major beat or miss for Q3 in the sector.

​Earlier on September 25, Teva Pharmaceutical Industries Limited (NYSE:TEVA) released its Aide Mémoires ahead of its Q3 results scheduled for November 5, 2025. As per the report, management expects full-year revenue in the range of $16.8 billion and $17.2 billion, reflecting 2% to 4% increase year-over-year. The outlook is in line with the general consensus of $16.901 billion.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is an international drug maker that sells a range of generic, specialty, and OTC products.

Page 9 of 12